ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 100 filers reported holding ADMA BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,665,000 | +41525.0% | 910,000 | +45196.2% | 0.00% | – |
| Q1 2021 | $4,000 | -81.8% | 2,009 | -80.6% | 0.00% | – |
| Q4 2020 | $22,000 | +214.3% | 10,338 | +270.5% | 0.00% | – |
| Q3 2020 | $7,000 | -98.5% | 2,790 | -98.2% | 0.00% | – |
| Q2 2020 | $455,000 | +18.8% | 158,821 | +7.5% | 0.00% | – |
| Q1 2020 | $383,000 | -33.5% | 147,803 | +2.5% | 0.00% | – |
| Q4 2019 | $576,000 | +2780.0% | 144,137 | +3164.7% | 0.00% | – |
| Q3 2019 | $20,000 | +122.2% | 4,415 | +89.5% | 0.00% | – |
| Q2 2019 | $9,000 | – | 2,330 | +19316.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 12 | -95.7% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 279 | +108.2% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 134 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |